Andrew Dudum - 12 Feb 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
12 Feb 2024
Net transactions value
-$1,888,919
Form type
4
Filing time
14 Feb 2024, 20:50:38 UTC
Previous filing
29 Jan 2024
Next filing
01 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $198,145 +81,541 +158% $2.43 133,194 12 Feb 2024 Direct F1
transaction HIMS Class A Common Stock Sale $814,040 -81,541 -61% $9.98 51,653 12 Feb 2024 Direct F1, F2
transaction HIMS Class A Common Stock Options Exercise $236,215 +97,208 +188% $2.43 148,861 13 Feb 2024 Direct F1
transaction HIMS Class A Common Stock Sale $931,010 -97,208 -65% $9.58 51,653 13 Feb 2024 Direct F1, F3
transaction HIMS Class A Common Stock Options Exercise $188,038 +77,382 +150% $2.43 129,035 14 Feb 2024 Direct F1
transaction HIMS Class A Common Stock Sale $766,268 -77,382 -60% $9.90 51,653 14 Feb 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -81,541 -3% $0.000000 2,655,613 12 Feb 2024 Class A Common Stock 81,541 $2.43 Direct F5
transaction HIMS Stock Option (right to buy) Options Exercise $0 -97,208 -3.7% $0.000000 2,558,405 13 Feb 2024 Class A Common Stock 97,208 $2.43 Direct F5
transaction HIMS Stock Option (right to buy) Options Exercise $0 -77,382 -3% $0.000000 2,481,023 14 Feb 2024 Class A Common Stock 77,382 $2.43 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.82 - $10.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.15 - $9.79. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.71 - $10.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5 Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.